Meloxicam and Celebrex (celecoxib) are not the same medication, but they belong to the same broader family of anti-inflammatory drugs and treat many of the same conditions. Both reduce pain and inflammation by targeting an enzyme called COX-2, which drives swelling in your joints and tissues. The key difference is how precisely each one hits that target, which affects their side effect profiles, cost, and how they’re prescribed.
How They Work Differently
Both meloxicam and celecoxib are classified as COX-2 selective inhibitors, meaning they preferentially block the enzyme responsible for inflammation (COX-2) while mostly sparing COX-1, which protects the stomach lining. But they sit on a spectrum. Celecoxib was specifically designed as a highly selective COX-2 inhibitor and is the only one in its class still on the U.S. market. Meloxicam is considered “preferentially” selective for COX-2, meaning it still inhibits some COX-1 activity, especially at higher doses. In practice, this makes meloxicam behave more like a traditional NSAID (think ibuprofen or naproxen) than celecoxib does.
Conditions They Treat
The overlap here is significant. Both drugs are FDA-approved for osteoarthritis and rheumatoid arthritis. Meloxicam also carries an approval for juvenile rheumatoid arthritis in children aged 2 and older. Celecoxib has a broader label that includes acute pain and menstrual pain, conditions meloxicam isn’t officially approved for (though it’s sometimes prescribed off-label for general pain).
If your doctor is choosing between the two for arthritis, the decision usually comes down to your stomach history, heart risk, and insurance coverage rather than effectiveness. Both provide comparable pain relief for joint inflammation.
Stomach and GI Side Effects
This is where the COX-2 selectivity difference matters most. A large prescription-event monitoring study tracking thousands of patients in England found that celecoxib caused 23% fewer upper GI symptoms (acid reflux, stomach pain) and 44% fewer serious complications like stomach bleeding or perforations compared to meloxicam. In raw numbers, 7.2% of meloxicam patients had symptomatic upper GI events versus 6.0% on celecoxib. For serious bleeds and perforations, the rates were 0.4% for meloxicam and 0.2% for celecoxib.
If you have a history of stomach ulcers or GI bleeding, celecoxib’s stronger COX-2 selectivity gives it a meaningful edge. That said, neither drug is risk-free for your stomach, and both carry less GI risk than older NSAIDs like ibuprofen or naproxen taken at full doses.
Heart and Cardiovascular Risk
All NSAIDs, including both of these drugs, carry warnings about increased cardiovascular risk. This became a major concern after rofecoxib (Vioxx), a COX-2 inhibitor, was pulled from the market in 2004 for causing heart attacks. Celecoxib has been studied extensively since then. A large case-control study comparing various anti-inflammatory drugs found no statistically significant increase in heart attack risk with celecoxib at standard doses, while ibuprofen and diclofenac both showed elevated risk.
However, a cancer prevention trial found that celecoxib at high doses (400 mg twice daily, double the typical arthritis dose) carried a 3.4 times greater risk of cardiovascular events than placebo. The takeaway: at normal prescribed doses for arthritis, celecoxib appears relatively safe for the heart, but risk climbs with dose and duration. Meloxicam’s cardiovascular profile is less extensively studied on its own, but it carries the same class-wide FDA warning as all NSAIDs.
How You Take Them
Meloxicam is typically taken once a day. For osteoarthritis, most people start at 7.5 mg daily, with a maximum of 15 mg. Celecoxib is usually taken once or twice daily depending on the condition, with 200 mg per day being a common dose for arthritis.
Celecoxib reaches peak levels in your blood within 2 to 3 hours. Meloxicam takes longer, reaching its peak somewhere between 2.5 and 7 hours after a dose. Both need several days of consistent use to build up their full anti-inflammatory effect, so you shouldn’t judge either one based on the first dose alone.
The Sulfa Allergy Question
One practical difference worth knowing: celecoxib contains a sulfonamide chemical group, and its labeling lists sulfonamide allergy as a contraindication. This has led to confusion, since many people are told they have a “sulfa allergy” based on a reaction to sulfonamide antibiotics like Bactrim. Research suggests the cross-reactivity risk is likely overstated because celecoxib lacks the specific chemical structure (an aromatic amine) that causes most allergic reactions to sulfa antibiotics. Still, many prescribers avoid celecoxib in patients with a documented sulfa allergy and may choose meloxicam instead, since it doesn’t contain a sulfonamide group at all.
Cost Comparison
Generic meloxicam is one of the least expensive anti-inflammatory options available. A 100-tablet supply of 15 mg tablets runs roughly $8 to $12 without insurance. Generic celecoxib costs more, typically $15 to $33 for 100 capsules of 200 mg. Both are widely available as generics (Celebrex lost its patent exclusivity years ago), but meloxicam is still noticeably cheaper. For many people paying out of pocket, this price gap is the deciding factor.
Which One Is Better for You
Neither drug is universally better. They treat the same core conditions with similar effectiveness, but their differences matter depending on your health profile. Celecoxib tends to be gentler on the stomach and may be preferred if you have a history of ulcers or GI problems. Meloxicam is significantly cheaper and a solid choice for people without major GI risk factors. If you have a sulfa allergy on your chart, meloxicam avoids that concern entirely. And if cardiovascular risk is your primary worry, both drugs require the same caution: use the lowest effective dose for the shortest time needed.